Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411162 · ClinicalTrials.gov registry record · Phase 1
A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream
A Phase 1 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT02411162 is a Phase 1 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 15 participants.
The verdict
NCT02411162, a Phase 1 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
This will be an open-label, non-randomized, single-center study to assess the residency of GSK2894512 in the skin of healthy adult male volunteers with normal barrier function. The study will have two parts, Cohort 1 (Part A) followed by Cohort 2 (Part B). The study will assess the residence time in human skin . The primary objective is to evaluate the residency time in skin following topical application of two formulations of GSK2894512 Cream. The total study duration will be of 15 days including 1 to 7 days of treatment period, 8 to 14 days of post treatment period and 1 day of follow up. The screening period will be up to 28 days prior to Baseline (Day 1).
Interventions
- DRUG Combination therapy GSK2894512 Cream A + GSK2894512 Cream B
- DRUG Combination therapy Vehicle Cream A + Vehicle Cream B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-07-07 |
| Est. Completion | 2015-09-24 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02411162
The ClinicalTrials.gov registry entry for NCT02411162 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stiefel, a GSK Company, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Combination therapy GSK2894512 Cream A + GSK2894512 Cream B is the first listed.
NCT02411162 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02411162 about?
NCT02411162 is a clinical study titled "A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream". This will be an open-label, non-randomized, single-center study to assess the residency of GSK2894512 in the skin of healthy adult male volunteers with normal barrier function. The study will have two parts, Cohort 1 (Part A) followed by Cohort 2 (Part B). The study will assess the residence time in...
What is the current status of trial NCT02411162?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2015-07-07. Estimated completion is 2015-09-24.
What interventions are being tested in trial NCT02411162?
The interventions under investigation include: Combination therapy GSK2894512 Cream A + GSK2894512 Cream B (DRUG), Combination therapy Vehicle Cream A + Vehicle Cream B (DRUG).
Who is sponsoring clinical trial NCT02411162?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.